GO:1900076 regulation of cellular response to insulin stimulus: Signaling Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1900076 describes any process that modulates the frequency, rate or extent of the cellular response to insulin stimulus.
Insulin receptor stimulation triggers an immediate-early transcriptional response that is a key component of this regulation.
The term encompasses both positive and negative modulation of insulin signaling at the cellular level.
Dysregulation of this process is linked to metabolic disorders, hypothalamic dysfunction, and altered insulin granule dynamics.
Key genes involved include INSR, IGF1R, and downstream effectors such as ZBTB7A (LRF) that influence insulin-responsive gene expression.
CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the causal roles of genes in this regulatory process.

Description

The Gene Ontology (GO) term GO:1900076, regulation of cellular response to insulin stimulus, is a biological process that encompasses any mechanism controlling the frequency, rate, or extent of how a cell responds to insulin. Insulin is a critical anabolic hormone, and its cellular effects range from glucose uptake to transcriptional reprogramming. The regulation of these responses ensures metabolic homeostasis and is fundamental to understanding diseases such as diabetes and insulin resistance. Researchers studying this term investigate the signaling cascades, feedback loops, and transcriptional networks that fine-tune insulin sensitivity. The immediate-early transcriptional response to insulin receptor stimulation is a well-characterized example of such regulation, involving rapid changes in gene expression that shape the cell's long-term adaptation. This article provides a comprehensive overview of GO:1900076, integrating authoritative GO definitions with real PubMed literature to support researchers in experimental design and data interpretation.

regulation of cellular response to insulin stimulus At A Glance

GO ID GO:1900076
GO term regulation of cellular response to insulin stimulus
Ontology biological_process
Synonym none
Major function Modulation of cellular responses to insulin, including signaling and gene expression
Related process Insulin receptor signaling pathway, glucose homeostasis
Key regulators INSR, IGF1R, ZBTB7A, and immediate-early transcription factors
Disease relevance Metabolic disorders, hypothalamic dysfunction, insulin resistance

What Is GO:1900076?

GO:1900076 is defined as any process that modulates the frequency, rate or extent of cellular response to insulin stimulus. In other words, it covers all molecular events that either enhance or suppress the cellular reaction to insulin, including changes in signaling intensity, duration, and downstream transcriptional outputs.

Why Is regulation of cellular response to insulin stimulus Important in Cell Biology?

Understanding GO:1900076 is crucial because insulin signaling is central to metabolic health, and its dysregulation underlies major diseases such as type 2 diabetes, obesity, and neurodegenerative conditions. The regulation of cellular insulin responses determines how effectively cells take up glucose, store energy, and adapt to nutritional changes. Moreover, insulin receptor stimulation triggers an immediate-early transcriptional response that can reprogram cellular behavior, influencing long-term outcomes like proliferation, differentiation, and survival. Research into this process also intersects with hypothalamic function, where insulin sensing contributes to systemic energy balance. Therefore, dissecting the regulatory mechanisms of insulin response is essential for developing targeted therapies and for interpreting genomic and proteomic data in metabolic research.
Insulin resistance is a hallmark of type 2 diabetes, and its molecular basis lies in altered regulation of insulin response.
The immediate-early transcriptional response to insulin controls genes involved in metabolism, growth, and survival.
Hypothalamic insulin signaling regulates whole-body energy homeostasis and is implicated in obesity.
Insulin granule dynamics and secretion are modulated by regulatory processes that can be studied with advanced techniques like dielectrophoresis.
IGF-1 signaling, which shares components with insulin signaling, mediates mechanotransduction in bone and muscle.
Transcription factors such as ZBTB7A (LRF) influence insulin-responsive gene expression and metabolic pathways.
Dysregulation of insulin response contributes to cancer progression through altered growth factor signaling.
CRISPR screens can identify novel regulators of insulin response, accelerating target discovery.
Understanding this process aids in the development of insulin sensitizers and other therapeutics.
It provides a framework for integrating multi-omics data in metabolic disease research.

What Happens During regulation of cellular response to insulin stimulus?

Insulin Receptor Activation and Immediate-Early Transcription
In simple terms: When insulin binds to its receptor, it quickly turns on a set of early-response genes.
Insulin binding to the insulin receptor (INSR) triggers autophosphorylation and activation of downstream signaling cascades, including the PI3K/AKT and MAPK pathways. This leads to an immediate-early transcriptional response, where transcription factors such as FOS, JUN, and EGR1 are rapidly induced. This response modulates the expression of genes involved in glucose metabolism, cell growth, and survival, thereby regulating the cellular response to insulin stimulus.
Feedback Regulation of Insulin Signaling
In simple terms: Cells have built-in brakes to prevent insulin signaling from going out of control.
Negative feedback loops are critical for regulating the intensity and duration of insulin signaling. For example, prolonged insulin stimulation leads to phosphorylation of insulin receptor substrate (IRS) proteins by kinases such as JNK and PKC, which attenuates downstream signaling. Additionally, phosphatases like PTEN and SHIP2 dephosphorylate key lipid second messengers, dampening the response. These regulatory mechanisms ensure that cellular responses to insulin are appropriately terminated, preventing hyperactivation that could lead to pathological states.
Transcriptional and Epigenetic Control
In simple terms: Long-term changes in gene expression are controlled by transcription factors and chromatin modifications.
Beyond immediate-early genes, insulin regulates the expression of a wide array of genes through transcription factors such as ZBTB7A (LRF), which can act as a repressor or activator depending on context. Epigenetic modifications, including histone acetylation and DNA methylation, also contribute to sustained changes in insulin responsiveness. These transcriptional and epigenetic mechanisms fine-tune the cellular response to insulin over longer timescales, influencing metabolic phenotype.
Regulation of Insulin Granule Dynamics
In simple terms: In pancreatic beta cells, insulin is stored in granules, and their movement and release are tightly regulated.
In insulin-secreting cells, the cellular response to insulin stimulus includes regulation of insulin granule subpopulations. Dielectrophoresis studies have revealed that stimulus-induced remodeling of insulin granule subpopulations occurs, affecting secretion dynamics. This regulation is essential for proper insulin release and glucose homeostasis, and its dysfunction contributes to diabetes.

Key Genes Involved in GO:1900076 regulation of cellular response to insulin stimulus

The following genes and proteins are central to the regulation of cellular response to insulin stimulus, as supported by published literature.
GeneMajor RoleResearch Relevance
INSR Insulin receptor; initiates signaling upon insulin binding Core regulator; mutations cause insulin resistance syndromes
IGF1R IGF-1 receptor; shares downstream pathways with INSR Mediates mechanotransduction and growth; crosstalk with insulin signaling
IRS1 Insulin receptor substrate 1; adaptor protein in insulin signaling Key node for feedback regulation and insulin sensitivity
IRS2 Insulin receptor substrate 2; mediates metabolic effects of insulin Important for beta-cell function and survival
PIK3CA Catalytic subunit of PI3K; generates PIP3 Drives AKT activation; frequently mutated in cancer
AKT1 Serine/threonine kinase; central mediator of insulin action Regulates glucose uptake, growth, and survival
FOXO1 Forkhead transcription factor; downstream of AKT Controls gluconeogenic and lipogenic gene expression
ZBTB7A Transcription factor (LRF); regulates insulin-responsive genes Modulates metabolic and proliferative responses
FOS Immediate-early transcription factor Induced rapidly by insulin; part of AP-1 complex
JUN Immediate-early transcription factor Forms AP-1; regulates proliferation and stress responses
EGR1 Early growth response protein 1 Mediates insulin-induced gene expression
MAPK1 ERK2; mitogen-activated protein kinase Transmits insulin signals to nucleus
MAPK3 ERK1; mitogen-activated protein kinase Complements ERK2 in insulin signaling
PTEN Lipid phosphatase; negative regulator of PI3K/AKT Tumor suppressor; modulates insulin sensitivity
SHIP2 Inositol polyphosphate 5-phosphatase Negative regulator of insulin signaling
SLC2A4 GLUT4 glucose transporter Mediates insulin-stimulated glucose uptake
PCK1 Phosphoenolpyruvate carboxykinase 1 Rate-limiting enzyme in gluconeogenesis; repressed by insulin
G6PC Glucose-6-phosphatase Catalyzes final step of gluconeogenesis; repressed by insulin

How Is regulation of cellular response to insulin stimulus Regulated?

The regulation of cellular response to insulin stimulus is itself tightly controlled by multiple mechanisms. Negative feedback loops involving kinases such as JNK, PKC, and S6K phosphorylate IRS proteins, reducing their ability to transmit signals. Phosphatases like PTEN and SHIP2 dephosphorylate PIP3, terminating PI3K signaling. Additionally, transcriptional repressors such as ZBTB7A can modulate the expression of insulin-responsive genes, providing long-term regulation. Hypothalamic insulin signaling is also subject to regulation by nutrient status and hormones, influencing whole-body energy balance. These layered regulatory mechanisms ensure that insulin responses are appropriate to the physiological context.

regulation of cellular response to insulin stimulus and Human Disease

GeneDisease / BiologyPotential Experimental Model
INSRInsulin resistance, type 2 diabetesKnockout or point-mutation cell lines to study signaling defects
IGF1RCancer, growth disordersOverexpression or knockout models to assess proliferation
ZBTB7AMetabolic regulation, cancerKnockout and rescue experiments to dissect transcriptional roles
PTENCancer, insulin hypersensitivityKnockout models to study enhanced insulin signaling
SLC2A4Type 2 diabetes, glucose uptake defectsKnock-in of tagged GLUT4 for trafficking studies
Insulin Resistance and Type 2 Diabetes
Dysregulation of GO:1900076 is a hallmark of insulin resistance, a precursor to type 2 diabetes. Impaired negative feedback and chronic inflammation lead to serine phosphorylation of IRS proteins, which attenuates insulin signaling. This results in reduced glucose uptake and increased hepatic gluconeogenesis, contributing to hyperglycemia. Understanding the regulatory nodes involved can identify therapeutic targets for insulin sensitizers.
Hypothalamic Dysfunction and Obesity
The hypothalamus plays a key role in sensing insulin and regulating energy balance. Hypothalamic dysfunction, including impaired insulin signaling, is associated with obesity and metabolic syndrome. Regulation of cellular response to insulin stimulus in hypothalamic neurons affects food intake and energy expenditure, making it a critical area for obesity research.
Cancer and Growth Factor Signaling
Insulin and IGF-1 signaling pathways are frequently hijacked in cancer to promote proliferation and survival. Overactivation of INSR and IGF1R, or loss of negative regulators like PTEN, can lead to uncontrolled growth. The regulation of cellular response to insulin stimulus thus intersects with oncogenic signaling, and targeting these pathways is a therapeutic strategy.

From regulation of cellular response to insulin stimulus-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate insulin-stimulated glucose uptake?Knockout cell line (e.g., 3T3-L1 adipocytes)
Does a specific point mutation in INSR affect signaling?Point-mutation knock-in via CRISPR
How does a risk variant affect insulin response?Knock-in of the variant allele in a relevant cell type
Where is the protein localized during insulin stimulation?Tagged knock-in (e.g., GFP) for imaging
Does overexpression of gene Y enhance insulin sensitivity?Overexpression cell model
What are the immediate-early transcriptional targets?RNA-seq after insulin stimulation in wild-type and KO cells

How to Study the regulation of cellular response to insulin stimulus Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal gene expression changesIdentify immediate-early and late insulin-responsive genes
PhosphoproteomicsPhosphorylation dynamics of signaling proteinsMap insulin signaling networks and feedback
DielectrophoresisInsulin granule subpopulation remodelingStudy stimulus-induced granule dynamics
CRISPR knockout screenLoss-of-function effects on insulin responseDiscover novel regulators
CRISPR activation screenGain-of-function effects on insulin responseIdentify enhancers of insulin sensitivity
Live-cell imagingProtein translocation and localizationVisualize GLUT4 trafficking or receptor internalization
Western blotProtein expression and phosphorylationValidate key signaling nodes
qRT-PCRExpression of specific genesConfirm RNA-seq findings
Transcriptomic Profiling
RNA-seq is widely used to measure the immediate-early and long-term transcriptional changes induced by insulin. By comparing wild-type and knockout cells, researchers can identify genes whose regulation depends on specific factors. This method provides a global view of the cellular response to insulin stimulus.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation status following insulin stimulation. This is particularly useful for mapping signaling cascades and feedback loops that regulate insulin response. Phosphoproteomics can reveal dynamic changes in IRS1, AKT, and other key nodes.
Imaging and Granule Dynamics
Advanced imaging techniques, such as dielectrophoresis, allow real-time monitoring of insulin granule subpopulations and their remodeling upon stimulation. Fluorescence microscopy with tagged proteins can visualize translocation of GLUT4 or other effectors. These methods provide spatial and temporal resolution of regulatory events.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens can identify novel regulators of insulin response. Cells are stimulated with insulin, and readouts such as glucose uptake or reporter gene expression are used to select for candidates. This unbiased approach can uncover previously unknown components of GO:1900076.

How CRISPR Can Be Used to Study GO:1900076 regulation of cellular response to insulin stimulus

Knockout

CRISPR knockout is used to delete candidate genes and assess their requirement for insulin response. For example, knocking out INSR or IRS1 abolishes insulin signaling, while knocking out negative regulators like PTEN enhances it. Knockout models are essential for establishing causality in GO:1900076 research.

Point Mutation

Point mutations can be introduced to model disease-associated variants or to dissect specific phosphorylation sites. For instance, mutating serine residues in IRS1 to alanine can prevent feedback phosphorylation and alter insulin sensitivity. CRISPR-based point mutation allows precise editing without altering the rest of the genome.

Knock-in

Knock-in of tagged proteins (e.g., GFP, HA) enables visualization and purification of endogenous proteins. This is useful for studying the localization and interactome of insulin signaling components under native regulation. Knock-in of reporter genes can also create sensitive readouts for insulin response.

Overexpression

Overexpression of wild-type or mutant genes can test gain-of-function effects. For example, overexpressing a constitutively active AKT mimics insulin signaling, while overexpressing a dominant-negative mutant blocks it. Overexpression models complement knockout studies to provide a full picture of gene function in GO:1900076.

How EDITGENE Supports regulation of cellular response to insulin stimulus Research

Researchers studying regulation of cellular response to insulin stimulus-related genes often need to determine whether a candidate gene is causally involved in insulin signaling, and what its precise function is. This requires robust, reproducible cell models that can be engineered with high efficiency and specificity. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for regulation of cellular response to insulin stimulus research.

Related Products

Product name Cat.No. Species Gene ID
PPARG Knockout HEK293 Cell Line EDJ-KQ1115 Human 5468 Details Get a Quote
ATP2B1 Knockout HEK293 Cell Line EDJ-KQ1548 Human 490 Details Get a Quote
NCOA2 Knockout HEK293 Cell Line EDJ-KQ2687 Human 10499 Details Get a Quote
GPLD1 Knockout HEK293 Cell Line EDJ-KQ4755 Human 2822 Details Get a Quote
NCOA1 Knockout HEK293 Cell Line EDJ-KQ6316 Human 8648 Details Get a Quote
KBTBD2 Knockout HEK293 Cell Line EDJ-KQ8318 Human 25948 Details Get a Quote
ATP2B1 Knockout A-549 Cell Line EDJ-KQ19858 Human 490 Details Get a Quote
PPARG Knockout A-549 Cell Line EDJ-KQ20301 Human 5468 Details Get a Quote
PPARG(PPARγ) Knockout HCT 116 Cell Line EDC09847 Human 5468 Details Get a Quote
PPARG Knockout HeLa Cell Line EDJ-KQ20303 Human 5468 Details Get a Quote
ATP2B1 Knockout HCT 116 Cell Line EDJ-KQ21222 Human 490 Details Get a Quote
ATP2B1 Knockout HeLa Cell Line EDJ-KQ21223 Human 490 Details Get a Quote
NCOA2 Knockout A-549 Cell Line EDJ-KQ23505 Human 10499 Details Get a Quote
NCOA2 Knockout HCT 116 Cell Line EDJ-KQ23506 Human 10499 Details Get a Quote
NCOA2 Knockout HeLa Cell Line EDJ-KQ23507 Human 10499 Details Get a Quote
Displaying Records 1 To 15 Of 35 Records

Frequently Asked Questions About regulation of cellular response to insulin stimulus

GO:1900076 is a Gene Ontology term for regulation of cellular response to insulin stimulus, defined as any process that modulates the frequency, rate or extent of cellular response to insulin stimulus.
Key genes include INSR, IGF1R, IRS1, IRS2, PIK3CA, AKT1, FOXO1, ZBTB7A, FOS, JUN, EGR1, MAPK1, MAPK3, PTEN, SHIP2, SLC2A4, PCK1, and G6PC.
It is regulated by feedback phosphorylation of IRS proteins, lipid phosphatases like PTEN and SHIP2, transcriptional control by factors such as ZBTB7A, and epigenetic modifications.
Dysregulation is linked to type 2 diabetes, insulin resistance, obesity, hypothalamic dysfunction, and cancer.
Common methods include RNA-seq, phosphoproteomics, dielectrophoresis, CRISPR screens, live-cell imaging, Western blot, and qRT-PCR.
CRISPR can create knockout, point mutation, knock-in, and overexpression models to test the causal role of specific genes in insulin signaling.
It is the rapid induction of genes like FOS, JUN, and EGR1 following insulin receptor stimulation, which shapes the cellular response.
ZBTB7A (LRF) is a transcription factor that regulates insulin-responsive genes and influences metabolic and proliferative responses.
IGF-1 signaling shares downstream components with insulin signaling and can mediate mechanotransduction and growth.
Stimulus-induced remodeling of insulin granule subpopulations affects secretion dynamics and is important for glucose homeostasis.

Conclusion

GO:1900076, regulation of cellular response to insulin stimulus, is a critical biological process that integrates signaling, transcription, and feedback mechanisms to control how cells respond to insulin. Its dysregulation is central to metabolic diseases and cancer, making it a prime target for research. By leveraging CRISPR-based models and advanced omics technologies, researchers can dissect the precise roles of individual genes and pathways. EDITGENE provides the tools and expertise to accelerate these discoveries, from knockout and knock-in cell lines to genome-wide screens and bioinformatics support.

References

  1. 2. Casipit CG et al.. 2026. Hypothalamic Dysfunction.. PMID: 32809578
  2. 4. Constantinou C et al.. 2019. The multi-faceted functioning portrait of LRF/ZBTB7A.. Hum Genomics 13(1):66 PMID: 31823818
  3. 5. Tian F et al.. 2018. IGF-1 signaling mediated cell-specific skeletal mechano-transduction.. J Orthop Res 36(2):576-583 PMID: 28980721
  4. 6. Thiel G et al.. 2021. Immediate-early transcriptional response to insulin receptor stimulation.. Biochem Pharmacol 192:114696 PMID: 34302794
  5. 7. Archambeau A et al.. 2025. Dielectrophoresis Reveals Stimulus-Induced Remodeling of Insulin Granule Subpopulations.. bioRxiv PMID: 41280009
Contact Us
*
*
*
*
How did you hear about us: